BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2019 11:25:18 AM | Browse: 707 | Download: 930
Publication Name World Journal of Gastroenterology
Manuscript ID 47509
Country Italy
2019-03-17 09:23
Peer-Review Started
2019-03-18 09:25
To Make the First Decision
2019-04-17 00:20
Return for Revision
2019-04-17 02:16
2019-05-10 15:11
Second Decision
2019-05-17 09:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-05-18 12:44
Articles in Press
2019-05-18 12:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-07-13 11:40
Publish the Manuscript Online
2019-07-14 11:25
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
Manuscript Source Invited Manuscript
All Author List Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli and Nicola Coppola
Author(s) ORCID Number
Caterina Sagnelli http://orcid.org/0000-0002-6413-7810
Mariantonietta Pisaturo http://orcid.org/0000-0001-5870-0956
Federica Calò http://orcid.org/0000-0002-8817-3429
Salvatore Martini http://orcid.org/0000-0001-5214-1268
Evangelista Sagnelli http://orcid.org/0000-0003-2817-8436
Nicola Coppola http://orcid.org/0000-0001-5897-4949
Funding Agency and Grant Number
Corresponding Author Caterina Sagnelli, MD, PhD, Assistant Professor, Associate Professor, Chief Doctor, Reader (Associate Professor), Department of Mental Health and Public Medicine, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, Via L. Armanni 5, Naples 80135, Italy. caterina.sagnelli@unicampania.it
Key Words Hepatitis B virus reactivation; Hepatitis B virus infection; Hemo-lymphoproliferative diseases; Immunosuppressive therapy; Hepatitis B virus therapy; Hepatitis B virus prophylasis
Core Tip Hepatitis B virus (HBV) reactivation frequently exerts a negative impact on the outcome of patients with hemo-lymphoproliferative disorders both by liver injury, at times severe, and a premature delay or termination of immunosuppressive treatments. Patients at risk should be identified by screening of HBV serum markers before immunosuppressive therapy is started. The use of HBV nucle(t)side analogues, as treatment or prophylaxis, is effective in limiting the frequency and intensity of the damage caused. Antivirals should be administered 2-3 wk before starting immunosuppressive treatment, for the entire immunosuppressive period and during post-treatment follow-up, the length of which depends on the intensity of immunosuppression reached.
Publish Date 2019-07-14 11:25
Citation Sagnelli C, Pisaturo M, Calò F, Martini S, Sagnelli E, Coppola N. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World J Gastroenterol 2019; 25(26): 3299-3312
URL https://www.wjgnet.com/1007-9327/full/v25/i26/3299.htm
DOI https://dx.doi.org/10.3748/wjg.v25.i26.3299
Full Article (PDF) WJG-25-3299.pdf
Full Article (Word) WJG-25-3299.docx
Manuscript File 47509-Review.docx
Answering Reviewers 47509-Answering reviewers.pdf
Audio Core Tip 47509-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 47509-Conflict-of-interest statement.pdf
Copyright License Agreement 47509-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 47509-Language certificate.pdf
Peer-review Report 47509-Peer-review(s).pdf
Scientific Misconduct Check 47509-Scientific misconduct check.pdf
Scientific Editor Work List 47509-Scientific editor work list.pdf
CrossCheck Report 47509-CrossCheck Report.pdf